1979
DOI: 10.1016/0002-9149(79)90081-x
|View full text |Cite
|
Sign up to set email alerts
|

Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
17
0
2

Year Published

1981
1981
2007
2007

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 114 publications
(23 citation statements)
references
References 33 publications
2
17
0
2
Order By: Relevance
“…Several clinical trials have reported an improvement in hemodynamic measurements and reduced mortality in patients receiving intravenous glucose alone or in the form of a glucose infusion containing insulin and potassium during acute myocardial infarction (45)(46)(47)(48). It is well established that within minutes after acute coronary occlusion metabolic changes result that, if prolonged, adversely affect myocardial cell survival.…”
Section: Discussionmentioning
confidence: 99%
“…Several clinical trials have reported an improvement in hemodynamic measurements and reduced mortality in patients receiving intravenous glucose alone or in the form of a glucose infusion containing insulin and potassium during acute myocardial infarction (45)(46)(47)(48). It is well established that within minutes after acute coronary occlusion metabolic changes result that, if prolonged, adversely affect myocardial cell survival.…”
Section: Discussionmentioning
confidence: 99%
“…This value distinctly exceeds the 13 % calculated by a shift of the ATP/ O ratio from 2.80 to 3.17 when myocardial metabolism is converted from lipid to glucose utilization. Nevertheless, because of hyperosmolality, side effects or toxicity (18,19,20,21,24,25) the clinically applicable substance to achieve this goal is as yet not found.…”
Section: Discussionmentioning
confidence: 99%
“…In the pre treated group, no elevations in resting CF and resting LVP were observed during hypoper fusion (0.3±0.1 4g and -1.0±0. 3 dmmHg at the end of hypoperfusion, respectively). In the post-treated group, these elevations were similar to those in the non-treated group (3.1 ±0.4 4g and 10.1 ±4.4 dmmHg at the end of hypoperfusion, respectively).…”
Section: Animals and Treatmentmentioning
confidence: 96%